logo

Supernus Pharmaceuticals, Inc. (SUPN)



Trade SUPN now with
  Date
  Headline
9/14/2020 8:26:50 AM Supernus Submits NDA To FDA For Its Apomorphine Infusion Pump SPN-830
11/11/2014 5:32:53 PM Supernus Pharmaceuticals, Inc. (SUPN) Has Raised Its FY14 Revenue Estimate To $115 - $118 Mln From $105 Mln